MetaStat Stock Forecast, Price & News

0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
Today's Range
Now: $0.02
50-Day Range
MA: $0.02
52-Week Range
Now: $0.02
Average Volume21,107 shs
Market Capitalization$117,576.00
P/E RatioN/A
Dividend YieldN/A
MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company's therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.
MetaStat logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:MTST
Year FoundedN/A



Sales & Book Value

Annual Sales$20,000.00



Market Cap$117,576.00
Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.00 out of 5 stars

Medical Sector

1884th out of 2,010 stocks

Pharmaceutical Preparations Industry

744th out of 769 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MTST News and Ratings via Email

Sign-up to receive the latest news and ratings for MTST and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

MetaStat (OTCMKTS:MTST) Frequently Asked Questions

What stocks does MarketBeat like better than MetaStat?

Wall Street analysts have given MetaStat a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MetaStat wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting MetaStat?

MetaStat saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 100 shares, a decline of 66.7% from the February 28th total of 300 shares. Based on an average trading volume of 500 shares, the days-to-cover ratio is currently 0.2 days.
View MetaStat's Short Interest

Who are MetaStat's key executives?

MetaStat's management team includes the following people:
  • Mr. Douglas A. Hamilton B.Sc., MBA, CEO, Pres & Director (Age 55, Pay $413.5k)
  • Mr. Frederick E. Pierce II, VP of Investor Relations
  • Dr. Michael J. Donovan, Acting Chief Medical Officer (Age 67)

Who are some of MetaStat's key competitors?

What is MetaStat's stock symbol?

MetaStat trades on the OTCMKTS under the ticker symbol "MTST."

How do I buy shares of MetaStat?

Shares of MTST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MetaStat's stock price today?

One share of MTST stock can currently be purchased for approximately $0.02.

How much money does MetaStat make?

MetaStat has a market capitalization of $117,576.00 and generates $20,000.00 in revenue each year.

How many employees does MetaStat have?

MetaStat employs 6 workers across the globe.

What is MetaStat's official website?

The official website for MetaStat is www.metastat.com.

Where are MetaStat's headquarters?

MetaStat is headquartered at 27 DRYDOCK AVE. 2ND FLOOR, BOSTON MA, 02210.

How can I contact MetaStat?

MetaStat's mailing address is 27 DRYDOCK AVE. 2ND FLOOR, BOSTON MA, 02210. The company can be reached via phone at 617-531-6500 or via email at [email protected]

This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.